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Abstract
Background: Myasthenia gravis, an uncommon autoimmune syndrome, is commonly associated
with thymus abnormalities. Thymomatous myasthenia gravis is considered to have worst prognosis
and thymectomy can reverse symptoms if precociously performed.
Case report: We describe a case of a patient who underwent mitral valve repair and was found
to have an occasional thymomatous mass during the surgery. A total thymectomy was performed
concomitantly to the mitral valve repair.
Conclusion: The diagnosis of thymomatous myasthenia gravis was confirmed postoperatively.
Following the surgery this patient was strictly monitored and at 1-year follow-up a complete stable
remission had been successfully achieved.
Background
Myasthenia gravis (MG), an uncommon autoimmune
syndrome caused by the failure of neuromuscular trans-
mission, results from binding of autoantibodies to those
proteins that are involved in signaling at the neuromuscu-
lar junction [1].
The role of thymus in the pathogenesis of myasthenia
gravis is not entirely clear, but most patients with
myasthenia gravis are found to have some degree of thy-
mus abnormality. The thymus is hypothesized to be the
site of autoantibody formation and therefore thymectomy
has been proposed as a first line therapy. This is especially
true if a thymoma is present, as thymectomy has been
reported to significantly improve the clinical condition
[2].
Case presentation
We report a case of a 37-year-old white female who pre-
sented with an echocardiographic diagnosis of severe
mitral valve regurgitation and had a history of fatigue,
weakness and dyspnea on exertion for last three months.
Her symptoms were not further investigated considering
the severe mitral valvular disease. She had no other co-
morbidities and the preoperative EuroSCORE was 3. She
was scheduled for an elective mitral valve repair surgery.
The patient underwent routine median sternotomy. At
direct inspection of the retro-sternal space, the superior
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third of the anterior mediastinum was filled with a 2 × 1.5
cm mass arising from left lobe of thymus (Figure 1). The
mass was not invasive and easily resectable. No intraoper-
ative frozen sections were examined. However, A total
thymectomy was performed before opening the pericar-
dium. Thereafter, the classic mitral valve repair was per-
formed without any intraoperative or perioperative
complication.
In the postoperative stay, high titers of anti-acetylcholine
receptor antibodies and anti-striated muscle antibodies
were found (9.1 nmol/L and titer >1:80, respectively) and
myasthenia gravis was diagnosed. MG diagnosis was fur-
ther confirmed by the positive tensilon test. The severity of
MG was retrospectively evaluated in the postoperative
period according to the clinical classification of the Medi-
cal Scientific Advisory Board of the Myasthenia Gravis
Foundation of America (MGFA) [3]. The patient was clas-
sified to be in MGFA class IIa, as mild weakness involved
not only ocular muscles but also axial muscles while
oropharyngeal and respiratory muscles were not con-
cerned. The histopathologic examination of the specimen
revealed a completely excised thymoma. It was classified
as type A accordingly to new World Health Organization
classification of Rosai and Sabin (WHO type A or medul-
lary). Using the staging process described by Masaoka,
this specimen was staged to be as Masaoka Stage I since
macroscopically it was a completely encapsulated thy-
moma with no microscopically determined capsular inva-
sion [4].
The postoperative course was uneventful and the patient
was discharged on postoperative day 6 to home-rehabili-
tation in tele-cardiology without any complications. The
patient was strictly monitored by a multidisciplinary team
composed of a cardiologist, a surgeon and a neurologist
for regular follow-ups. No MG therapy was initiated con-
sidering the recent operation and the good clinical status.
At six-month follow-up, no mitral regurgitation was
detected by transthoracic echocardiography and the
symptoms related to MG were completely remitted. The
anti-acetylcholine receptor antibodies titer decreased to
4.2 nmol/L. At 1-year follow-up a complete stable remis-
sion (CSR) was assessed according to the MGFA Post-
Intervention Status Classification and the acetylcholine
receptor antibodies titer had further decreased to 1.4
nmol/L [3].
Conclusion
Thymomatous MG (T-MG) is considered to have worst
prognosis compared with non-thymomatous MG. The
patho-physiological bases are not clear but clinical data
suggest that patients with T-MG have high-grade symp-
toms with low rate of remission even after therapy [5].
In patients who undergo cardiac surgery, the evaluation of
the thymus is often considered secondary and tumoral
disease of the thymus is only considered when a mass is
found intraoperatively or at a CT scan. Few reports have
focused on the incidental finding of a thymic mass during
cardiac surgery and the management is generally guided
by the type and extension [6,7]. Total thymectomy is
advised if an encapsulated thymic mass or a resectable
invasive thymoma are found. However, histological
examination on frozen section should be performed first
if the malignant mass is unresectable or metastases are evi-
dent [8].
Moreover, the clinical evaluation usually represents the
first diagnostic step for a patient with suspected MG. The
evaluation of MG-related symptoms could be difficult as
they may get masked by the cardiac disease. In this report,
the preoperative clinical status was not correctly addressed
as the cardiac symptoms were predominant. Hence, the
diagnosis of thymomatous MG was guided by the intraop-
erative findings which led us to revaluate the preoperative
clinical conditions.
Although uncommon, MG represents an invalidating dis-
ease which has to be diagnosed as soon as possible in
order to initiate the appropriate therapy thereby increas-
ing the remission rate [1,3,5]. The clinical evaluation
should be more accurate in patients with cardiac disease
as initial MG symptoms could be masked resulting in an
underestimated or incorrect diagnosis. Moreover, the
meticulous evaluation of the thymus gland itself during
cardiac surgery can be an effective step towards finding
even small macroscopic abnormalities of thymus that
could be prophylactically excised. Therefore, a focus on
thymus during cardiac surgery may not only lead to an
The intraoperative finding of the small thymomatous mass  which led to the MG diagnosis Figure 1
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occasional intraoperative diagnosis of thymus abnormal-
ity but also results in re-evaluation of the clinical status
postoperatively to confirm the suspected concomitant T-
MG.
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